AMRX | Amneal Pharmaceuticals Inc
Category: Consumer goods
Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: Bridgewater Township, New Jersey, United States Trade prices Volume: Market Cap: 506.71M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: March 2, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 16, 2023 March 2, 2023 0.23 / 0.21610M / 579.84MBeat! November 4, 2022 0.14 / 0.18546M / 561.86MAugust 5, 2022 0.19 / 0.1944559.36M / 534.49MBeat! May 4, 2022 0.12 / 0.1286497.63M / 502.29Mview more
Historical Data Date Price Open High Low Vol Change ER May 4, 2022 3.730 3.920 3.920
3.265
2.64M -6.98% May 3, 2022 4.010 4.090 4.090
3.970
810.19K -0.5% May 2, 2022 4.030 3.870 4.030
3.820
925.21K 4.40% Apr 29, 2022 3.860 3.900 3.980
3.830
520.23K -2.28% Apr 28, 2022 3.950 3.910 3.980
3.800
421.09K 2.07% Apr 27, 2022 3.870 3.830 3.900
3.800
411.62K 0.78% Apr 26, 2022 3.840 3.830 3.895
3.760
907.94K -0.78% Apr 25, 2022 3.870 3.850 3.910
3.780
546.90K -1.02% Apr 22, 2022 3.910 3.990 4.000
3.885
477.88K -2.49% Apr 21, 2022 4.010 4.080 4.090
3.960
820.42K -1.47% view more
News
Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61M seekingalpha.com Nov 4, 2022 6:07 pm Amneal Pharmaceuticals Q3 2022 Earnings Preview seekingalpha.com Nov 4, 2022 1:22 am Amneal Pharma gets FDA nod for leuprolide acetate injection to treat prostate cancer seekingalpha.com Nov 2, 2022 9:20 pm Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance seekingalpha.com Aug 5, 2022 6:04 pm Amneal Pharmaceuticals Q2 2022 Earnings Preview seekingalpha.com Aug 5, 2022 1:38 am Endo adds over 27% after favorable trial verdict seekingalpha.com Jul 2, 2022 2:14 am AMD, JD and BILI are among pre market gainers seekingalpha.com Nov 2, 2022 9:11 pm Amneal Pharma submits NDA for novel formulation of Parkinson's disease treatment seekingalpha.com Sep 1, 2022 5:10 am Amneal shares lower after generic drugmaker cuts FY 2022 profit outlook seekingalpha.com Aug 6, 2022 12:06 am Amneal launches Lyvispah for muscle tightness due to spinal cord & neurological disorders seekingalpha.com Jun 1, 2022 9:29 pm Amneal, Kashiv's biosimilar therapy to Amgen's Neulasta gets FDA approval seekingalpha.com May 27, 2022 7:08 pm Pfizer COVID-19 antiviral priced at under $25 per course by generic drugmakers seekingalpha.com May 13, 2022 12:23 am Amneal falls 12% on disappointing Q1 result seekingalpha.com May 5, 2022 1:41 am Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M seekingalpha.com May 4, 2022 6:05 pm Amneal Pharmaceuticals Q1 2022 Earnings Preview seekingalpha.com May 3, 2022 11:18 pm Amneal Pharmaceuticals gets second U.S. biosimilar approval with FDA nod for Alymsys seekingalpha.com Apr 14, 2022 4:47 am Over 30 generic manufacturers agree to make Pfizer COVID-19 pill seekingalpha.com Mar 18, 2022 4:11 am Amneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimates seekingalpha.com Mar 3, 2022 1:09 am Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M seekingalpha.com Mar 2, 2022 7:02 pm Amneal Pharmaceuticals enters US biosimilar market with FDA nod for RELEUKOTM seekingalpha.com Mar 2, 2022 5:44 am Key Persons CEO : Chirag Patel (2019–), Chintu Patel (2019–) Talk about Amneal Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet